Navigation Links
Researchers question key quality measure for asthma
Date:10/4/2011

AURORA, Colo. -- Researchers studying the first national quality measure for hospitalized children have found that no matter how strictly a health care institution followed the criteria, it had no actual impact on patient outcomes.

The scientists examined 30 hospitals with 37,267 children admitted for asthma from 2008 to 2010 and discovered that the quality of discharge planning made no difference to the rate of return to the hospital for another asthma attack in 7, 30 or 90 days.

"Our research concluded that there is no relationship between compliance with this measure and readmission rates for asthma patients," said study co-author Marion Sills, MD, MPH and associate professor of pediatrics at the University of Colorado School of Medicine.

The findings have been published in October's Journal of the American Medical Association (JAMA).

Asthma is the leading cause of admissions in children's hospitals. To help provide the best care, the Joint Commission, a non-profit that accredits and certifies more than 19,000 health care organizations programs nationwide, adopted three core process measures for evaluating how hospitals treat childhood asthma.

The Children's Asthma Care (CAC) measures include giving asthma relievers upon admission, providing systemic corticosteroids and creating a home management plan of care when they are discharged. Hospitals' compliance with the first two measures was high and did not vary enough for researchers to study the impact on outcomes.

By studying hospitals' compliance with the third measure -- devising a home health management plan -- researchers concluded that it had no effect on hospital readmissions or return emergency department visits for asthma.

"No matter how well your hospital did in complying with this there was no difference in readmissions," Sills said. "For a parent trying to choose a hospital for a child with an asthma attack, this quality measure doesn't help determine which hospital will provide better care. From a policy standpoint, these measures may not meet the Joint Commission's own criteria for an accountability measure -- that compliance should lead to better outcomes. This is especially important for measures that will be used for public reporting and pay for performance. Requiring a hospital to meet a certain criteria of patient care and then finding out that it makes no difference is reason to reevaluate these measures."

The findings are significant because until recently none of the more than 50 Joint Commission measures evaluated care for hospitalized children. They have been used for numerous other conditions with varying success. For example, acute myocardial infarction mortality rates decreased but congestive heart failure death rates did not during times when compliance with process measures increased.

Sills and the other researchers concluded by saying the Joint Commission should reconsider whether a hospital's compliance with the CAC measures is suitable for public reporting, accreditation or pay for performance.


'/>"/>
Contact: David Kelly
david.kelly@ucdenver.edu
303-315-6374
University of Colorado Denver
Source:Eurekalert

Related medicine news :

1. Researchers from Boston University receive grant to develop improved virus detection system
2. Researchers review studies on CCSVI-MS link
3. Researchers call for more awareness of male breast cancer as cases rise
4. Researchers transform iPhone into high-quality medical imaging device
5. Fox Chase researchers identifiy more accurate treatment delivery for robotic radiosurgery system
6. Georgia Tech researchers receive 3 NSF Emerging Frontiers awards
7. Childrens National researchers make breakthrough in understanding white matter development
8. UH researchers explain hormonal role in glucose and fat metabolism
9. Researchers identify enzyme that regulates degradation of damaged proteins
10. UTHealth researchers train promotoras to combine mobile technology, cancer prevention messages
11. Researchers uncover gene associated with blood cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 2016 , ... W.S. Badger Co. Inc ., the maker of certified ... as one of the best small businesses for new dads by Fatherly, the digital ... businesses providing progressive benefits to new parents on the organization’s 2016 Best Places ...
(Date:5/27/2016)... ... ... This campaign aims to provide a path to improved education and awareness ... change. , As nearly 795,000 Americans suffering from a new or recurrent stoke each ... an estimated 129,000 of these people dying from stroke, it’s become our nation’s fifth-leading ...
(Date:5/27/2016)... Texas (PRWEB) , ... May 27, 2016 , ... ... satisfying Army body fat composition regulations. This is the first time that Coolsculpting ... normally screened at least every six months to ensure they meet the prescribed body-fat ...
(Date:5/27/2016)... ... 2016 , ... Each year Standard Process Inc. ... this year’s Life University winner of a $2,500 scholarship from Standard ... Awards ceremony. , Outerbridge is approaching her last quarter at Life University in ...
(Date:5/26/2016)... ... 26, 2016 , ... There are many ways to cook a hot dog, ... that Americans prefer their dogs straight off the grill. Of the 90 percent of ... way to cook a hot dog, far outpacing other cooking methods such as steaming ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
(Date:5/26/2016)... 2016   Change Healthcare , a ... solutions and technology-enabled services designed to enable ... a strategic channel partnership with SourceMed, the ... and revenue cycle management services that empower ... clinics to optimize revenue, operational efficiency and ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: